NEJM July 8, 2021
Carter Dredge, MHA & Stefan Scholtes, PhD

Leaders at Civica Rx have developed a potentially disruptive health care business model that enables private-sector efficiency and public-sector societal equity at scale.

Summary

The growth of the Civica Rx health care utility model of addressing shortages of pharmaceutical supplies for hospitals has been gathering momentum since its launch in 2018. The concept is to bypass the major drug makers and to manufacture or subcontract for generic pharmaceuticals that its 1,400-plus member hospitals need. What’s unique about the venture is that it is established as a nonstock, nonprofit 501(c)(4) social welfare organization. The money to run the operation comes from the customers (the hospitals) and philanthropic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma, Pharma / Biotech, Provider
GE, LG, Microsoft tie up for smart hospital project in Korea
How technology is bringing cardiology, cardiac surgery together
The Digital Transformation of Nursing
Feds Seeking to Save Medicare Money on High-Volume, High-Cost Procedures
Mayo Clinic $5B expansion sparks financial planning reboot

Share This Article